Get startedLog in
    Picture of Incyte logo

    INCY — Incyte News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareBalancedLarge CapHigh Flyer
    All News

    Brief: Incyte To Acquire Vega Therapeutics, A Wholly Owned Subsidiary Of Star Therapeutics, Expanding Its Hematology Portfolio Into Bleeding Disorders

    Picture of Incyte logoIncyte
    08/06/2026 12:08
    BRIEF-Incyte To Acquire Vega Therapeutics, A Wholly Owned Subsidiary Of Star Therapeutics, Expanding Its Hematology Portfolio Into Bleeding Disorders
    June 8 (Reuters) - Incyte Corp INCY.O:
    • INCYTE TO ACQUIRE VEGA THERAPEUTICS, A WHOLLY OWNED SUBSIDIARY OF STAR THERAPEUTICS, EXPANDING ITS HEMATOLOGY PORTFOLIO INTO BLEEDING DISORDERS
    • INCYTE - TO BUY VEGA THERAPEUTICS FOR $1.25 BILLION
    • INCYTE - DEAL VALUE UP TO $2 BILLION INCLUDING $750 MILLION IN SALES MILESTONES
    • INCYTE - DEAL EXPECTED TO CLOSE IN Q3 2026 WITH $1.25 BILLION RD CHARGE
    Source text: ID:nBw1WY6D2a
    Further company coverage: INCY.O

     ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Incyte

    See all news